Mobile-Menu

The Top 10 Largest Pharmaceutical Mergers in History

4th place - Bristol-Myers Squibb/Celgene (72.6 Billion Dollar): 'The best of pharmaceuticals combined with the best of biotech', was how the two company directors Giovanni Caforio (Bristol-Myers Squibb) and Mark Alles (Celgene) presented the transaction at a conference call. The background to the acquisition is Bristol-Myers Squibb's objectives in the booming cancer drug market. Final closing is expected in the third quarter of 2019. With an estimated sales volume of 22.3 billion dollar, the Americans will be number two in oncology after Roche. (Pfizer) arrow back arrow forward Image Zoom
4th place - Bristol-Myers Squibb/Celgene (72.6 Billion Dollar): 'The best of pharmaceuticals combined with the best of biotech', was how the two company directors Giovanni Caforio (Bristol-Myers Squibb) and Mark Alles (Celgene) presented the transaction at a conference call. The background to the acquisition is Bristol-Myers Squibb's objectives in the booming cancer drug market. Final closing is expected in the third quarter of 2019. With an estimated sales volume of 22.3 billion dollar, the Americans will be number two in oncology after Roche. (Pfizer)
10/14
Back to the Article